Discovery of the RANKL/RANK/OPG system
H Yasuda - Journal of bone and mineral metabolism, 2021 - Springer
Almost a quarter century has passed since discovery of receptor activator of NF-κB ligand
(RANKL). This discovery had a major impact on identification of mechanisms regulating …
(RANKL). This discovery had a major impact on identification of mechanisms regulating …
Post-stroke inflammation—target or tool for therapy?
KL Lambertsen, B Finsen, BH Clausen - Acta neuropathologica, 2019 - Springer
Inflammation is currently considered a prime target for the development of new stroke
therapies. In the acute phase of ischemic stroke, microglia are activated and then circulating …
therapies. In the acute phase of ischemic stroke, microglia are activated and then circulating …
[HTML][HTML] Tumour necrosis factor signalling in health and disease
J Holbrook, S Lara-Reyna, H Jarosz-Griffiths… - …, 2019 - ncbi.nlm.nih.gov
The master pro-inflammatory cytokine, tumour necrosis factor (TNF), has been shown to
modulate multiple signalling pathways, with wide-ranging downstream effects. TNF plays a …
modulate multiple signalling pathways, with wide-ranging downstream effects. TNF plays a …
Role of TNF–TNF receptor 2 signal in regulatory T cells and its therapeutic implications
Tumor necrosis factor α (TNFα) is a pleiotropic cytokine which signals through TNF receptor
1 (TNFR1) and TNF receptor 2 (TNFR2). Emerging evidence has demonstrated that TNFR1 …
1 (TNFR1) and TNF receptor 2 (TNFR2). Emerging evidence has demonstrated that TNFR1 …
Anti-TNF therapy in Crohn's disease
SO Adegbola, K Sahnan, J Warusavitarne… - International journal of …, 2018 - mdpi.com
Crohn's disease (CD) accounts for a variety of clinical manifestations or phenotypes that
stem from chronic inflammation in the gastrointestinal tract. Its worldwide incidence is …
stem from chronic inflammation in the gastrointestinal tract. Its worldwide incidence is …
[HTML][HTML] TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants–past, present and future
LM Sedger, MF McDermott - Cytokine & growth factor reviews, 2014 - Elsevier
Abstract Tumor Necrosis Factor (TNF), initially known for its tumor cytotoxicity, is a potent
mediator of inflammation, as well as many normal physiological functions in homeostasis …
mediator of inflammation, as well as many normal physiological functions in homeostasis …
Molecular mechanisms of T cell co-stimulation and co-inhibition
Co-stimulatory and co-inhibitory receptors have a pivotal role in T cell biology, as they
determine the functional outcome of T cell receptor (TCR) signalling. The classic definition of …
determine the functional outcome of T cell receptor (TCR) signalling. The classic definition of …
TNF-α signalling and inflammation: interactions between old acquaintances
H Zelová, J Hošek - Inflammation research, 2013 - Springer
Introduction Inflammation is a very important part of innate immunity and is regulated in
many steps. One such regulating step is the cytokine network, where tumor necrosis factor α …
many steps. One such regulating step is the cytokine network, where tumor necrosis factor α …
[HTML][HTML] The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease
K Sawada, H Chung, S Softic, ME Moreno-Fernandez… - Cell Metabolism, 2023 - cell.com
Metabolic dysfunction-associated steatotic liver disease (MASLD) is an unabated risk factor
for end-stage liver diseases with no available therapies. Dysregulated immune responses …
for end-stage liver diseases with no available therapies. Dysregulated immune responses …
Psoriasis: keratinocytes or immune cells–which is the trigger?
F Benhadou, D Mintoff, V Del Marmol - Dermatology, 2019 - karger.com
Background: Psoriasis is a common, chronic inflammatory skin disorder, which can
significantly impact quality of life. Despite major breakthroughs in our understanding of the …
significantly impact quality of life. Despite major breakthroughs in our understanding of the …